| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/1986 | EP0194207A2 Purified antigen from non-A, non-B Hepatitis causing factor |
| 09/10/1986 | EP0194006A1 Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them |
| 09/10/1986 | EP0193910A2 Synthesis of a derivative of GRF and intermediate peptides |
| 09/10/1986 | EP0193882A2 Production of peptides containing gamma-glutamic acid unities, cystein-enriched, process for their preparation and their use |
| 09/10/1986 | EP0193881A2 Method and reagent for the determination of a luteinizing hormone, as well as the appropriate monoclonal hormone |
| 09/10/1986 | EP0193880A2 Method and reagent for the determination of a follicle-stimulating hormone, as well as the appropriate monoclonal antibody |
| 09/10/1986 | EP0193608A1 Gif-2 and its preparation |
| 09/10/1986 | EP0193576A1 Monoclonal antibodies and their use |
| 09/10/1986 | CN86101353A Production method for interleukin-2 |
| 09/10/1986 | CN85109506A Method for the preparation of vaccine |
| 09/09/1986 | US4611054 Glucagon, growth hormone and insulin release inhibitors |
| 09/09/1986 | US4610976 Porcine GRF |
| 09/09/1986 | US4610815 Process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form |
| 09/09/1986 | CA1211060A1 Viruses with recombinant surface proteins |
| 09/09/1986 | CA1211059A1 RECOMBINANT PLASMID CONTAINING HUMAN INTERFERON-.beta. GENE |
| 09/03/1986 | EP0193515A2 Method for obtaining biologically active bovine and porcine growth hormone and composition comprising biologically active porcine growth hormone |
| 09/03/1986 | EP0193431A1 Monoclonal antibodies against chlamydial genus specific lipopolysaccharide |
| 09/03/1986 | EP0193351A2 Cationic oligopeptides having microbicidal activity |
| 09/03/1986 | EP0193349A2 Isolation, purification and sequence determination of cardionatrins III and IV |
| 09/03/1986 | EP0193259A1 Modifying plants by genetic engineering to combat or control insects |
| 09/03/1986 | EP0193256A1 Thiazolidinedione derivatives, their production and use |
| 09/03/1986 | EP0193175A2 Modified hirudines, process for their preparation and pharmaceutical agents containing them |
| 09/03/1986 | EP0193161A2 Antibody hybrid molecules and process for their preparation |
| 09/03/1986 | EP0193112A2 cDNA encoding mammalian insulin-like growth factor II |
| 09/03/1986 | EP0193032A2 Composition comprising or containing cytokinin, process for its preparation, DNA sequence and its use |
| 09/03/1986 | EP0192988A2 Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom |
| 09/03/1986 | EP0192902A2 DNA sequences from Varicella-zoster virus, vectors and hosts containing them, the corresponding polypeptides and the compositions containing them |
| 09/03/1986 | EP0192828A2 Novel, immunosuppressive compounds, a microbiological method for their preparation and their use as medicaments |
| 09/03/1986 | EP0192811A1 Cysteine-depleted muteins of biologically active proteins, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins |
| 09/03/1986 | EP0192743A1 Modified insulin precursors products and processes |
| 09/03/1986 | EP0192742A1 Cyclic polypeptides having mu-receptor specificity |
| 09/03/1986 | EP0192738A1 Expression of human connective tissue activator and related peptides |
| 09/03/1986 | EP0192728A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192727A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192726A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192725A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192705A1 Detachment of anchorage-dependent cells from microcarriers |
| 09/03/1986 | EP0192679A1 Yeast cloning vehicles |
| 09/03/1986 | EP0192677A1 Processes for recovery of products from waxy barley. |
| 09/03/1986 | EP0192658A1 Retroviral gene transfer vectors |
| 09/03/1986 | CN86101830A Production of proteins in procaryotes |
| 09/02/1986 | US4609725 Mono-iodinated tyrosine derivative |
| 09/02/1986 | US4609549 Antidiabetic, pertussis vaccine |
| 09/02/1986 | CA1210768A1 Derivatives of cis, endo-2- azabicyclo[5.3.0]decane-3-carboxylic acid, a process for their preparation, agents containing these derivatives and their use |
| 09/02/1986 | CA1210759A1 Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis |
| 09/02/1986 | CA1210757A1 Theophylline immunogens, antibodies, labeled conjugates, and related derivatives |
| 09/02/1986 | CA1210722A1 Glycopeptide bioconversion products |
| 09/02/1986 | CA1210720A1 Method for the purification of leucocytosis-promoting factor hemagglutinin (lpf-ha) |
| 09/02/1986 | CA1210715A1 Multiclass hybrid interferons |
| 09/02/1986 | CA1210714A1 .alpha.-INTERFERON GX-1 |
| 09/02/1986 | CA1210695A1 Haemophilus influenzae b polysaccharide exotoxoid conjugate vaccine |
| 08/28/1986 | WO1986004922A1 cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS |
| 08/28/1986 | WO1986004920A1 Human metallothionein-ii promoter in mammalian expression system |
| 08/28/1986 | WO1986004783A1 Neovascularization inhibitors and methods for their production and use |
| 08/28/1986 | WO1986004782A1 Monoclonal antibodies and method of immunizing therewith |
| 08/27/1986 | EP0192629A2 Method of somatotropin solubilization and naturation |
| 08/27/1986 | EP0192626A1 Malaria vaccine |
| 08/27/1986 | EP0192565A1 Method for the immunological determination of amines, monoclonal antobodies and test kit for carrying out the method |
| 08/27/1986 | EP0192492A2 Peptides containing an aliphatic-aromatic ketone side chain |
| 08/27/1986 | EP0192393A2 Alkylaminofuranone derivatives |
| 08/27/1986 | EP0192392A2 Insulin receptor, its purification, its production in recombinant cells, DNA therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them |
| 08/27/1986 | EP0192319A2 Cellular encapsulation of biological pesticides |
| 08/27/1986 | EP0192175A2 Rhinovirus strain HRV2 polypeptides and DNA molecules encoding them |
| 08/27/1986 | EP0192135A2 Oligopeptidylargininol derivatives and their homologues, process for their preparation, their use and agents containing them |
| 08/27/1986 | EP0192033A2 Chlamydia major outer membrane protein |
| 08/27/1986 | EP0192001A2 Papilloma virus probes and in vitro methods for the diagnosis of papilloma virus infections |
| 08/27/1986 | EP0191869A1 Fish calcitonin derivative, process for its preparation, and gene system therefor |
| 08/27/1986 | EP0191854A1 Antiviral peptides |
| 08/27/1986 | EP0191846A1 Method of producing monoclonal anti-idiotypic antibodies |
| 08/26/1986 | US4608364 Pharmaceutical agent for the treatment of diabetes mellitus |
| 08/26/1986 | US4608339 Dilution with polyoxyethylene glycol |
| 08/26/1986 | US4608254 Method for the production of therapeutically administrable plasma derivatives filled in final containers |
| 08/26/1986 | US4608199 Bone protein purification process |
| 08/26/1986 | CA1210347A1 Microbial hybrid promotors |
| 08/26/1986 | CA1210345A1 A.t.c.c.hb8209 and its monoclonal antibody to erythropoietin |
| 08/20/1986 | EP0191748A1 Malaria vaccine |
| 08/20/1986 | EP0191651A2 Method of diagnosing syphilis |
| 08/20/1986 | EP0191606A2 Vectors and methods for expression of human protein C activity |
| 08/20/1986 | EP0191349A2 A peptide compound and antiserum produced by using this compound |
| 08/20/1986 | EP0191221A1 Vectors for transformation of ascomycetes |
| 08/20/1986 | EP0191049A1 Antibody production |
| 08/20/1986 | CN86100915A Method of somatotropin solubilization and naturation |
| 08/20/1986 | CN85109718A Regnlatory site of expression for heterogeneic gene in yeast |
| 08/19/1986 | US4607023 Natriuretic |
| 08/19/1986 | US4607009 Lewis blood group phenotype assay |
| 08/19/1986 | US4606856 [Des-1-amino, 8-glycine]calcitonin |
| 08/19/1986 | US4606825 Purification of immunoglobulin G |
| 08/19/1986 | CA1209979A1 Substrate capable of adsorbing protein |
| 08/14/1986 | WO1986004609A1 A process for producing human growth hormone |
| 08/14/1986 | WO1986004608A1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
| 08/14/1986 | WO1986004607A1 Recombinant colony stimulating factor-1 |
| 08/14/1986 | WO1986004606A1 Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins |
| 08/14/1986 | WO1986004605A1 Human granulocyte colony stimulating factor |
| 08/14/1986 | WO1986004604A1 A 987p fimbriae-producing microorganism, a vaccine for the immunization of pigs as well as a method for production of the vaccine |
| 08/14/1986 | WO1986004589A1 Fsh |
| 08/14/1986 | WO1986004588A1 Protein which is characteristic of rheumatoid arthritis |
| 08/14/1986 | WO1986004587A1 Purification of native colony stimulating factor-1 |
| 08/14/1986 | WO1986004506A1 Infection-protective agent containing human granulocyte colony-stimulating factor as effective ingredient |
| 08/14/1986 | WO1986004486A1 Method for purifying antihemophilic factor |
| 08/14/1986 | WO1986003751A3 Purification, production and use of tumor necrosis factors |